Study Evaluating AMG 706 in Subjects With Advanced Solid Tumors

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

NCT00813384 ·Status: COMPLETED ·Phase: PHASE1

AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00324597 ·Status: UNKNOWN ·Phase: PHASE1

A Study of AMG 337 in Subjects With Advanced Solid Tumors

NCT01253707 ·Status: COMPLETED ·Phase: PHASE1

Safety Study of AMG 228 to Treat Solid Tumors

NCT02437916 ·Status: TERMINATED ·Phase: PHASE1

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

NCT05800964 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors

NCT01137552 ·Status: TERMINATED ·Phase: PHASE1

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

NCT04293094 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1/2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

NCT05975073 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors

NCT00974896 ·Status: COMPLETED ·Phase: PHASE1

A Study of AMG 820 in Subjects With Advanced Solid Tumors

NCT01444404 ·Status: COMPLETED ·Phase: PHASE1

A Study of AMG 355 Alone and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors

NCT06131398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function

NCT01331941 ·Status: COMPLETED ·Phase: PHASE1

Study of 23ME-01473 in Patients With Advanced Solid Malignancies

NCT06290388 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors

NCT00858377 ·Status: COMPLETED ·Phase: PHASE1

SJG-136 in Treating Patients With Advanced Solid Tumors

NCT00103220 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

NCT05317078 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Multicenter Open-label Study to Evaluate the Safety Tolerability and PK of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies

NCT02013804 ·Status: COMPLETED ·Phase: PHASE1

3D011-08 Monotherapy in Subjects With Advanced Solid Tumors

NCT05099536 ·Status: WITHDRAWN ·Phase: PHASE1

First in Human Study of M1069 in Advanced Solid Tumors

NCT05198349 ·Status: TERMINATED ·Phase: PHASE1

A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.

NCT01441388 ·Status: WITHDRAWN ·Phase: PHASE1

A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)

NCT03600883 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

NCT00820560 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer

NCT00539383 ·Status: COMPLETED ·Phase: PHASE1

A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)

NCT05094336 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

JMT106 Injection in the Treatment of Advanced Solid Tumors

NCT07275073 ·Status: RECRUITING ·Phase: PHASE1